"It's rewarding to see the value that Atherotech places on our mission of education and advancing the practice of clinical lipidology for the NLA and its members," said Christopher Seymour, Executive Director of the National Lipid Association. "The NLA greatly appreciates this generous grant in support of our educational programming and objectives."
Atherotech upholds the educational mission of the NLA and contributes to its goals of engaging members in clinical lipidology. Atherotech will partner with the NLA to offer advanced lipid testing and inflammatory markers seminars and support the organization's three scientific meetings:
-- Spring Clinical Lipid Update held March 9-11 in San Diego, Calif.
-- NLA Annual Scientific Sessions held May 31-June 3 in Scottsdale, Ariz.
-- Summer Clinical Update September 14-16 in Charlotte, N.C.
"Atherotech is committed to educating the physician community on advances in improved cardiovascular risk assessment and personalized treatment strategies to improve patient outcomes," said Atherotech CEO Michael Mullen. "We're proud to support the NLA in its mission."